Seagen Inc.
Biological Products, (No Diagnostic Substances) · 21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021
官方登记数据
0位关注者
1997成立于
关于 Seagen Inc.
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington, was considered the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells, with its development of drugs such as Adcetris, Padcev, and Tivdak. Antibody-drug conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021
成立1997
法律形式C Corporation
状态营业中
专利889 项专利
ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATESUS20260242481A1 · 2026
TREATING LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER WITH ANTI-191P4D12 ANTIBODY DRUG CONJUGATES IN COMBINATION WITH PEMBROLIZUMABEP4780498A1 · 2026
关键数据
法律信息
| 法定名称 | Seagen Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1060736在 SEC EDGAR 上查看 ↗ |
| EIN | 91-1874389 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面